Literature DB >> 24928806

Initiating dopaminergic treatment in Parkinson's disease.

Anthony E Lang1, Connie Marras2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24928806     DOI: 10.1016/S0140-6736(14)60962-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson's disease: a meta-analysis.

Authors:  Cheng-long Xie; Yun-Yun Zhang; Xiao-Dan Wang; Jie Chen; Yi-He Chen; Jia-Lin Pa; Shi-Yi Lin; Hua-Zhen Lin; Wen-Wen Wang
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

2.  Supervised versus unsupervised technology-based levodopa monitoring in Parkinson's disease: an intrasubject comparison.

Authors:  Giovanna Lopane; Sabato Mellone; Mattia Corzani; Lorenzo Chiari; Pietro Cortelli; Giovanna Calandra-Buonaura; Manuela Contin
Journal:  J Neurol       Date:  2018-03-29       Impact factor: 4.849

Review 3.  Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease.

Authors:  Luxi Wang; Nian Xiong; Jinsha Huang; Shiyi Guo; Ling Liu; Chao Han; Guoxin Zhang; Haiyang Jiang; Kai Ma; Yun Xia; Xiaoyun Xu; Jie Li; Jing Y Liu; Tao Wang
Journal:  Front Aging Neurosci       Date:  2017-06-28       Impact factor: 5.750

Review 4.  Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist.

Authors:  Jinglin Zhang; Louis Chew-Seng Tan
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

5.  Estimates of Intracellular Dopamine in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Jonathan Sackner-Bernstein
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.